ERBB2 and breast cancer: Expression experiments initially identified four breast cancer ‘intrinsic’ subtypes (basal-like, HER2-enriched, luminal and normal breast-like) [2], and subsequent studies have led to the sub-stratification of luminal breast cancers into luminal A and luminal B and shown that this classification system is of prognostic significance [3].